| PRECLINICAL | evidence | New studies with stable gastric pentadecapeptide protecting gastrointestinal tract. significance of counteraction of vascular and multiorgan failure of occlusion/occlusion-like syndrome in cytoprotection/organoprotection. | BPC 157 | Gut barrier & GI healing | 2024-10-01 |
| PRECLINICAL | evidence | Stable Gastric Pentadecapeptide BPC 157 and Intestinal Anastomoses Therapy in Rats-A Review. | BPC 157 | — | 2024-08-17 |
| PRECLINICAL | evidence | The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity. | BPC 157 | — | 2024-04-03 |
| PRECLINICAL | evidence | From Selye's and Szabo's Cysteamine-Duodenal Ulcer in Rats to Dopamine in the Stomach: Therapy Significance and Possibilities. | BPC 157 | — | 2023-12-07 |
| PRECLINICAL | evidence | Stable Gastric Pentadecapeptide BPC 157 Therapy: Effect on Reperfusion Following Maintained Intra-Abdominal Hypertension (Grade III and IV) in Rats. | BPC 157 | — | 2023-11-02 |
| PRECLINICAL | evidence | Stable Isotope Labeling-Based Nontargeted Strategy for Characterization of the In Vitro Metabolic Profile of a Novel Doping BPC-157 in Doping Control by UHPLC-HRMS. | BPC 157 | — | 2023-10-30 |
| PRECLINICAL | evidence | Pentadecapeptide BPC 157 as Therapy for Inferior Caval Vein Embolization: Recovery of Sodium Laurate-Post-Embolization Syndrome in Rats. | BPC 157 | — | 2023-10-23 |
| PRECLINICAL | evidence | Stable Gastric Pentadecapeptide BPC 157-Possible Novel Therapy of Glaucoma and Other Ocular Conditions. | BPC 157 | — | 2023-07-24 |
| PRECLINICAL | evidence | Antiarrhythmic Sotalol, Occlusion/Occlusion-like Syndrome in Rats, and Stable Gastric Pentadecapeptide BPC 157 Therapy. | BPC 157 | — | 2023-07-07 |
| PRECLINICAL | evidence | Innate Vascular Failure by Application of Neuroleptics, Amphetamine, and Domperidone Rapidly Induced Severe Occlusion/Occlusion-like Syndromes in Rats and Stable Gastric Pentadecapeptide BPC 157 as Therapy. | BPC 157 | — | 2023-05-25 |
| PRECLINICAL | evidence | Stable Gastric Pentadecapeptide BPC 157 May Recover Brain-Gut Axis and Gut-Brain Axis Function. | BPC 157 | — | 2023-04-30 |
| PRECLINICAL | evidence | Stable Gastric Pentadecapeptide BPC 157: Prompt Particular Activation of Collateral Pathways. | BPC 157 | — | 2023-01-01 |
| PRECLINICAL | evidence | Stable Gastric Pentadecapeptide BPC 157 and Striated, Smooth, and Heart Muscle. | BPC 157 | — | 2022-12-12 |
| PRECLINICAL | evidence | Fourier Transform Infrared Spectroscopy Reveals Molecular Changes in Blood Vessels of Rats Treated with Pentadecapeptide BPC 157. | BPC 157 | — | 2022-12-04 |
| PRECLINICAL | evidence | Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Peptide Therapy in the Heart Disturbances, Myocardial Infarction, Heart Failure, Pulmonary Hypertension, Arrhythmias, and Thrombosis Presentation. | BPC 157 | — | 2022-10-25 |
| PRECLINICAL | evidence | BPC 157, L-NAME, L-Arginine, NO-Relation, in the Suited Rat Ketamine Models Resembling "Negative-Like" Symptoms of Schizophrenia. | BPC 157 | — | 2022-06-21 |
| PRECLINICAL | evidence | Therapy Effect of the Stable Gastric Pentadecapeptide BPC 157 on Acute Pancreatitis as Vascular Failure-Induced Severe Peripheral and Central Syndrome in Rats. | BPC 157 | — | 2022-06-01 |
| PRECLINICAL | evidence | Novel Therapeutic Effects in Rat Spinal Cord Injuries: Recovery of the Definitive and Early Spinal Cord Injury by the Administration of Pentadecapeptide BPC 157 Therapy. | BPC 157 | — | 2022-04-27 |
| PRECLINICAL | evidence | The anti-nociceptive effect of BPC-157 on the incisional pain model in rats. | BPC 157 | — | 2022-04-01 |
| PRECLINICAL | evidence | Pentadecapeptide BPC 157 and the central nervous system. | BPC 157 | — | 2022-03-01 |
| PRECLINICAL | evidence | Stable Gastric Pentadecapeptide BPC 157 May Counteract Myocardial Infarction Induced by Isoprenaline in Rats. | BPC 157 | — | 2022-01-26 |
| PRECLINICAL | evidence | Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome. | BPC 157 | Gut barrier & GI healing | 2022-01-07 |
| PRECLINICAL | evidence | Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs. | BPC 157 | — | 2022-01-01 |
| PRECLINICAL | evidence | Stable Gastric Pentadecapeptide BPC 157 Therapy of Rat Glaucoma. | BPC 157 | — | 2021-12-31 |
| PRECLINICAL | evidence | BPC 157 as Potential Treatment for COVID-19. | BPC 157 | — | 2021-11-09 |
| PRECLINICAL | evidence | Stable Gastric Pentadecapeptide BPC 157 as a Therapy for the Disable Myotendinous Junctions in Rats. | BPC 157 | — | 2021-10-27 |
| PRECLINICAL | evidence | Over-Dose Lithium Toxicity as an Occlusive-like Syndrome in Rats and Gastric Pentadecapeptide BPC 157. | BPC 157 | — | 2021-10-20 |
| PRECLINICAL | evidence | Robert's Intragastric Alcohol-Induced Gastric Lesion Model as an Escalated General Peripheral and Central Syndrome, Counteracted by the Stable Gastric Pentadecapeptide BPC 157. | BPC 157 | — | 2021-09-23 |
| PRECLINICAL | evidence | Stable Gastric Pentadecapeptide BPC 157 Heals Established Vesicovaginal Fistula and Counteracts Stone Formation in Rats. | BPC 157 | — | 2021-09-13 |
| PRECLINICAL | evidence | Physiological and Immunological Status of Adult Honeybees (Apis mellifera) Fed Sugar Syrup Supplemented with Pentadecapeptide BPC 157. | BPC 157 | — | 2021-09-09 |
| PRECLINICAL | evidence | Complex Syndrome of the Complete Occlusion of the End of the Superior Mesenteric Vein, Opposed with the Stable Gastric Pentadecapeptide BPC 157 in Rats. | BPC 157 | — | 2021-08-17 |
| PRECLINICAL | evidence | Stable Gastric Pentadecapeptide BPC 157 Therapy for Monocrotaline-Induced Pulmonary Hypertension in Rats Leads to Prevention and Reversal. | BPC 157 | — | 2021-07-15 |
| PRECLINICAL | evidence | Occluded Superior Mesenteric Artery and Vein. Therapy with the Stable Gastric Pentadecapeptide BPC 157. | BPC 157 | — | 2021-07-08 |
| PRECLINICAL | evidence | Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain. | BPC 157 | Bone & joint health | 2021-07-01 |
| PRECLINICAL | evidence | BPC 157 Therapy and the Permanent Occlusion of the Superior Sagittal Sinus in Rat: Vascular Recruitment. | BPC 157 | — | 2021-06-28 |
| PRECLINICAL | evidence | Occlusion of the Superior Mesenteric Artery in Rats Reversed by Collateral Pathways Activation: Gastric Pentadecapeptide BPC 157 Therapy Counteracts Multiple Organ Dysfunction Syndrome; Intracranial, Portal, and Caval Hypertension; and Aortal Hypotension. | BPC 157 | — | 2021-05-26 |
| PRECLINICAL | evidence | Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats. | BPC 157 | — | 2021-01-01 |
| PRECLINICAL | evidence | Corrigendum: Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats. | BPC 157 | — | 2021-01-01 |
| PRECLINICAL | evidence | BPC 157 as a Therapy for Retinal Ischemia Induced by Retrobulbar Application of L-NAME in Rats. | BPC 157 | — | 2021-01-01 |
| PRECLINICAL | evidence | Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. | BPC 157 | — | 2021-01-01 |
| PRECLINICAL | evidence | Bowel adhesion and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine in rats. | BPC 157 | — | 2020-11-08 |
| PRECLINICAL | evidence | Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway. | BPC 157 | — | 2020-10-13 |
| PRECLINICAL | evidence | Pentadecapeptide BPC 157 shortens duration of tetracaine- and oxybuprocaine-induced corneal anesthesia in rats. | BPC 157 | — | 2020-09-01 |
| PRECLINICAL | evidence | Pentadecapeptide BPC 157 resolves Pringle maneuver in rats, both ischemia and reperfusion. | BPC 157 | — | 2020-05-27 |
| PRECLINICAL | evidence | Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye's Stress Coping Response: Progress, Achievements, and the Future. | BPC 157 | Gut barrier & GI healing | 2020-03-15 |
| PRECLINICAL | evidence | Pentadecapeptide BPC 157 resolves suprahepatic occlusion of the inferior caval vein, Budd-Chiari syndrome model in rats. | BPC 157 | — | 2020-03-13 |
| PRECLINICAL | evidence | Fistulas Healing. Stable Gastric Pentadecapeptide BPC 157 Therapy. | BPC 157 | Gut barrier & GI healing | 2020-01-01 |
| PRECLINICAL | evidence | BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing Cytoprotection. | BPC 157 | — | 2020-01-01 |
| PRECLINICAL | evidence | In relation to NO-System, Stable Pentadecapeptide BPC 157 Counteracts Lidocaine-Induced Adverse Effects in Rats and Depolarisation In Vitro. | BPC 157 | — | 2020-01-01 |
| PRECLINICAL | evidence | Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. | BPC 157 | Tendon & ligament repair | 2019-08-01 |